VeriSIM Life
AI Drug Discovery & Development
San Francisco, United States · Founded 2017
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- verisimlife.com
- Last Round
- Series AJan 2022
- Rounds
- 2
About
AI-driven biosimulation platform that predicts patient outcomes to de-risk drug development for pharmaceutical companies and research institutions.
Summary
VeriSIM Life is an Artificial Intelligence company based in San Francisco, United States, founded in 2017. Its most recent funding was a Series A round in Jan 2022. Investors include Morpheus Ventures, Debiopharm Innovation and Serra Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company